Figure 4
EMSA (RAW 264.7 cells, 5 × 105 cell/ml) for NF-κB and AP-1 at 1 h after LPS stimulation (200 ng/ml). HDAC inhibitor, KBH-A42 was treated 1 h before LPS stimulation.
Figure 4 | Experimental & Molecular Medicine
EMSA (RAW 264.7 cells, 5 × 105 cell/ml) for NF-κB and AP-1 at 1 h after LPS stimulation (200 ng/ml). HDAC inhibitor, KBH-A42 was treated 1 h before LPS stimulation.
